Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Agilent Technologies, Inc. (A) vs Illumina, Inc. (ILMN)

Agilent Technologies, Inc. and Illumina, Inc. are both Diagnostics & Research companies. Agilent Technologies, Inc. is the larger, with a market value of $49.0B against $41.3B — 1.2× the size. Agilent Technologies, Inc. trades at the lower P/E: 33.9× against 50.4×. Agilent Technologies, Inc. grew revenue faster over the last twelve months: 8.60% against 4.88%. Agilent Technologies, Inc. has the higher net margin (19.5% vs 18.4%) and the lower return on invested capital (11.1% vs 17.5%). Across the 22 metrics below, Agilent Technologies, Inc. leads on 14 and Illumina, Inc. on 8.

Valuation

Metric A ILMN Diagnostics & Research median
P/E 33.95 50.39 33.95
P/S 6.61 9.16 4.87
P/B 6.62 14.50 3.12
Price to free cash flow 38.40 44.94 34.02
EV/EBITDA 26.50 35.99 25.20
EV/Sales 6.87 9.25 5.66
Earnings yield 2.95% 1.98% (1.75%)
Free cash flow yield 2.60% 2.23% (0.13%)

Profitability

Metric A ILMN Diagnostics & Research median
Gross margin 53.83% 66.39% 50.89%
Operating margin 22.23% 19.65% (8.57%)
Net margin 19.53% 18.36% (6.37%)
Free cash flow margin 17.19% 20.72% 0.00%
Return on equity 20.97% 32.38% (2.92%)
Return on assets 11.00% 12.95% (6.71%)
Return on invested capital 11.07% 17.46% 0.00%

Growth

Metric A ILMN Diagnostics & Research median
Revenue growth (TTM) 8.60% 4.88% 7.69%
EPS growth (last fiscal year) 3.16% 170.87% —
Revenue growth, 5-year CAGR 5.41% 6.04% 7.40%
Net income growth, 5-year CAGR 12.63% 5.32% 0.00%

Health

Metric A ILMN Diagnostics & Research median
Debt to equity 0.50 0.53 0.11
Current ratio 2.05 1.80 2.02
Net debt to EBITDA 0.71 (0.13) 0.78

Dividend

Metric A ILMN Diagnostics & Research median
Dividend yield 0.70% — 0.70%
Payout ratio 0.23 0.00 0.00

Size

Metric A ILMN Diagnostics & Research median
Market cap 49.02b 41.25b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack